US Broker Ratings

Capricor Therapeutics, Inc. (CAPR) Investor Outlook: Analyzing Potential Upside of Nearly 80%

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company based in San Diego, California, is making waves in the healthcare sector with its innovative approach to..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with 22.87% Potential Upside

Community Health Systems, Inc. (NYSE: CYH) operates at the heart of the U.S. healthcare sector, providing a broad spectrum of medical services through its general acute..

Immatics N.V. (IMTX) Stock Analysis: A 91.91% Potential Upside in Revolutionary Cancer Therapies

Immatics N.V. (NASDAQ: IMTX), a pioneering force in the biotechnology sector, is capturing the attention of investors with its cutting-edge T cell redirecting immunotherapies aimed at..

SI-BONE, Inc. (SIBN)

⚠️ No article content returned.

..

Rocket Pharmaceuticals (RCKT) Stock Analysis: Navigating a 74.94% Potential Upside in Biotech

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT) is a key player in the biotechnology sector, focusing on the development of genetic therapies for rare and devastating diseases. The..

Relay Therapeutics, Inc. (RLAY) Stock Analysis: Exploring a Potential 68.88% Upside in Precision Medicine

Relay Therapeutics, Inc. (NASDAQ: RLAY), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its cutting-edge approach to drug discovery. With a..

Replimune Group, Inc. (REPL) Stock Analysis: Unveiling a 70% Potential Upside in the Biotech Arena

Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company, is making significant strides in the healthcare sector with its innovative approach to cancer treatment. Focused on..

Day One Biopharmaceuticals, Inc. (DAWN) Stock Analysis: Unpacking the Potential of a Biotech Pioneer with 83.9% Revenue Growth

Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN), a commercial-stage biopharmaceutical company based in Brisbane, California, is making waves in the biotechnology sector with an impressive 83.9% revenue..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A 58.63% Potential Upside in the Biotech Sector

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology industry, is capturing the attention of investors with its promising drug pipeline and a significant..

Neuropace, Inc. (NPCE) Stock Analysis: Exploring a 45.50% Potential Upside

Neuropace, Inc. (NASDAQ: NPCE), a key player in the healthcare sector, specifically within the medical devices industry, is catching investor attention with a compelling potential upside..

Trevi Therapeutics, Inc. (TRVI) Investor Outlook: An 82.59% Potential Upside Sparks Interest

Trevi Therapeutics, Inc. (NASDAQ: TRVI), a clinical-stage biopharmaceutical company based in New Haven, Connecticut, is currently making waves in the biotechnology industry. With a robust market..

Cronos Group Inc. (CRON) Stock Analysis: Navigating a Complex Landscape with 47% Revenue Growth

Investors with an eye on Cronos Group Inc. (NASDAQ: CRON) are witnessing an intriguing narrative unfold in the burgeoning cannabis sector. As a key player in..

Butterfly Network, Inc. (BFLY) Stock Analysis: Unpacking a 34% Potential Upside in the Healthcare Sector

Butterfly Network, Inc. (NASDAQ: BFLY), a key player in the medical devices industry, has been capturing investor attention with its promising potential upside of 34.04%. Headquartered..

Iovance Biotherapeutics, Inc. (IOVA): Investor Outlook with 143.90% Potential Upside

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) is making waves in the biotechnology sector with its promising outlook for investors. With a market capitalization of $1.52 billion, Iovance..

Evolus, Inc. (EOLS) Stock Analysis: Exploring a 251% Potential Upside in the Aesthetic Market

Evolus, Inc. (NASDAQ: EOLS) is a name that might not instantly ring a bell for every investor, yet it has carved a niche for itself within..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges with a Potential Forward P/E of 11.08

Avanos Medical, Inc. (NYSE: AVNS), a key player in the medical devices sector, offers investors a unique blend of opportunities and challenges. With a market capitalization..

AnaptysBio, Inc. (ANAB) Investor Outlook: Unlocking 20% Upside Potential in Biotechnology

AnaptysBio, Inc. (NASDAQ: ANAB), a clinical-stage biotechnology company rooted in the heart of San Diego, California, is capturing the attention of investors with its robust pipeline..

Nuvation Bio Inc. (NUVB) Stock Analysis: 161% Potential Upside Beckons Investors

Nuvation Bio Inc. (NASDAQ: NUVB), a promising player in the biotechnology sector, has captured investor attention with a striking potential upside of 161.44%. This clinical-stage biopharmaceutical..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges with a 57% Potential Upside

RxSight, Inc. (NASDAQ: RXST), a pioneering medical technology company specializing in light adjustable intraocular lenses (LAL) for cataract surgery, finds itself at a crucial juncture. With..

Savara, Inc. (SVRA) Investor Outlook: Biotech Stock with Over 100% Potential Upside

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company, is capturing investor attention as it targets rare respiratory diseases. With a market capitalization of $1.07 billion, the..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds